BioCentury
ARTICLE | Company News

InNexus, NIH deal

July 12, 2010 7:00 AM UTC

InNexus and NIH's National Cancer Institute (NCI) amended a May deal to give InNexus access to additional immunotoxins to treat cancer. InNexus is using its Dynamic Cross Linking (DXL) antibody techn...